For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Tarsus Pharmaceuticals Inc (NASDAQ: TARS) closed at $40.14 down -3.86% from its previous closing price of $41.75. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 0.66 million shares were traded. TARS stock price reached its highest trading level at $42.13 during the session, while it also had its lowest trading level at $39.41.
Ratios:
For a deeper understanding of Tarsus Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.54 and its Current Ratio is at 5.57. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.21.
On November 20, 2023, Goldman started tracking the stock assigning a Neutral rating and target price of $19.Goldman initiated its Neutral rating on November 20, 2023, with a $19 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 17 ’25 when Farrow Jeffrey S sold 13,608 shares for $40.42 per share. The transaction valued at 550,035 led to the insider holds 36,704 shares of the business.
Farrow Jeffrey S bought 13,608 shares of TARS for $550,088 on Jun 17 ’25. On Jun 16 ’25, another insider, Lin Elizabeth Yeu, who serves as the Chief Medical Officer of the company, sold 1,006 shares for $41.08 each. As a result, the insider received 41,326 and left with 7,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARS now has a Market Capitalization of 1686449920 and an Enterprise Value of 1350903424. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.22 while its Price-to-Book (P/B) ratio in mrq is 4.92. Its current Enterprise Value per Revenue stands at 5.781 whereas that against EBITDA is -12.537.
Stock Price History:
The Beta on a monthly basis for TARS is 0.80, which has changed by 0.65253186 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, TARS has reached a high of $57.28, while it has fallen to a 52-week low of $20.08. The 50-Day Moving Average of the stock is -3.88%, while the 200-Day Moving Average is calculated to be -13.57%.
Shares Statistics:
For the past three months, TARS has traded an average of 633.40K shares per day and 553570 over the past ten days. A total of 42.00M shares are outstanding, with a floating share count of 38.25M. Insiders hold about 8.95% of the company’s shares, while institutions hold 101.21% stake in the company. Shares short for TARS as of 1752537600 were 8208464 with a Short Ratio of 12.96, compared to 1749772800 on 8111634. Therefore, it implies a Short% of Shares Outstanding of 8208464 and a Short% of Float of 20.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
